HomeCompareHBANN vs PFE

HBANN vs PFE: Dividend Comparison 2026

HBANN yields 30.41% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HBANN wins by $87.2K in total portfolio value
10 years
HBANN
HBANN
● Live price
30.41%
Share price
$25.09
Annual div
$7.63
5Y div CAGR
0.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$136.8K
Annual income
$18,472.25
Full HBANN calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — HBANN vs PFE

📍 HBANN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHBANNPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HBANN + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HBANN pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HBANN
Annual income on $10K today (after 15% tax)
$2,585.15/yr
After 10yr DRIP, annual income (after tax)
$15,701.41/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $6,618.49/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HBANN + PFE for your $10,000?

HBANN: 50%PFE: 50%
100% PFE50/50100% HBANN
Portfolio after 10yr
$93.2K
Annual income
$22,365.48/yr
Blended yield
24.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

HBANN
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Price Target
$16.20
-35.4% upside vs current
Range: $14.50 — $18.00
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HBANN buys
0
PFE buys
0
No recent congressional trades found for HBANN or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHBANNPFE
Forward yield30.41%6.13%
Annual dividend / share$7.63$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.1%13.2%
Portfolio after 10y$136.8K$49.6K
Annual income after 10y$18,472.25$26,258.71
Total dividends collected$94.1K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold
Analyst price target$16.20$27.50

Year-by-year: HBANN vs PFE ($10,000, DRIP)

YearHBANN PortfolioHBANN Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$13,744$3,044.39$9,153$693.39+$4.6KHBANN
2$18,621$3,914.50$8,593$849.25+$10.0KHBANN
3$24,886$4,961.40$8,336$1,066.78+$16.6KHBANN
4$32,831$6,203.04$8,437$1,384.80+$24.4KHBANN
5$42,785$7,655.70$9,013$1,875.40+$33.8KHBANN
6$55,113$9,333.43$10,306$2,680.72+$44.8KHBANN
7$70,219$11,247.54$12,820$4,101.38+$57.4KHBANN
8$88,540$13,406.18$17,673$6,826.70+$70.9KHBANN
9$110,552$15,814.05$27,543$12,591.86+$83.0KHBANN
10$136,763$18,472.25$49,560$26,258.71+$87.2KHBANN

HBANN vs PFE: Complete Analysis 2026

HBANNStock

Huntington Bancshares Incorporated operates as a holding company for The Huntington National Bank that provides commercial, small business, consumer, and mortgage banking services. The company operates through four business segments: Consumer and Business Banking, Commercial Banking, Vehicle Finance, and Regional Banking and The Huntington Private Client Group (RBHPCG). The Consumer and Business Banking segment offers financial products and services, such as checking accounts, savings accounts, money market accounts, certificates of deposit, consumer loans, mortgage loans, credit cards, and small business loans, as well as investment products. It also provides insurance, interest rate risk protection, foreign exchange, and treasury management services, as well as online, mobile, and telephone banking services. The Commercial Banking segment offers banking solutions and asset finance services; corporate risk management services; institutional sales, trading, and underwriting services; institutional corporate banking services; treasury management services; and other financing solutions, as well as lends real estate developers, REITs, and other customers. The Vehicle Finance segment provides financing to consumers for the purchase of automobiles, light-duty trucks, recreational vehicles, and marine craft at franchised and other select dealerships, as well as to franchised dealerships for the acquisition of new and used inventory. The RBHPCG segment provides deposits, lending, banking, wealth management, investment and portfolio management, fiduciary administration, trust, retirement plan, and institutional and mutual fund custody services. As of January 23, 2020, the company operated through 868 full-service branches, including 12 private client group offices, and 1,448 automated teller machines located in 7 Midwestern states. Huntington Bancshares Incorporated was founded in 1866 and is headquartered in Columbus, Ohio.

Full HBANN Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this HBANN vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HBANN vs SCHDHBANN vs JEPIHBANN vs OHBANN vs KOHBANN vs MAINHBANN vs JNJHBANN vs MRKHBANN vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.